Skip to content

Ketamine: all studies

Page 441 of 449: studies 4,401 to 4,410 of 4,486, newest first. Back to the ketamine overview

Research

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

International review of neurobiology 2007 Daniel C Javitt

Schizophrenia is a serious mental disorder that affects up to 1% of the population worldwide. As of yet, neurochemical mechanisms underlying schizophrenia remain unknown. To date, the most widely considered neurochemical hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia may result from excess dopaminergic neurotransmission particularly in...

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Archives of General Psychiatry August 1, 2006 Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. 3,762 citations

CONTEXT: Existing therapies for major depression have a lag of onset of action of several weeks, resulting in considerable morbidity. Exploring pharmacological strategies that have rapid onset of antidepressant effects within a few days and that are sustained would have an enormous impact on patient care. Converging lines of evidence suggest the role of the glutamatergic system in the...

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Brazilian Journal of Medical and Biological Research April 1, 2006 Antônio Waldo Zuardi, José A. Crippa, Jaime E. C. Hallak et al. 411 citations

A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic...

Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Neuropsychopharmacology February 2006 Euphrosyne Gouzoulis‐mayfrank, Karsten Heekeren, Anna Neukirch et al.

Patients with schizophrenia exhibit disturbances of orienting of attention. However, findings have been inconsistent. Pharmacologic challenges with hallucinogens have been used as models for psychosis. The NMDA antagonist state (PCP, ketamine) resembles undifferentiated psychoses with positive and negative symptoms, while the 5-HT(2A) agonist state (LSD, dimethyltryptamine (DMT)) is thought to...

Enhancement of long-term potentiation at CA1-subiculum synapses in MK-801-treated rats.

Neuroscience Letters January 9, 2006 Nadine Buck, Sebat Cali, Joachim Behr

The subiculum plays a key role in processing neuronal information from the hippocampus to different cortical and subcortical brain regions. The subicular projections to the nucleus accumbens and the prefrontal cortex have received increasing attention, as alterations of their activity seem to be involved in schizophrenia. Phencyclidine and other non-competitive antagonists of NMDA receptors...

Orienting of attention in the 5HT2A agonist and NMDA antagonist model of psychosis

Pharmacopsychiatry September 1, 2005 Euphrosyne Gouzoulis‐mayfrank, Karsten Heekeren, Anna Neukirch et al.

Patients with schizophrenia exhibit disturbances of orienting of attention. However, findings have been inconsistent. Hallucinogen challenges have been used as models for psychosis. The NMDA antagonist state resembles undifferentiated psychoses, whereas the 5-HT2A agonist state is considered as a model for psychoses with prominent positive symptoms. The aim of this study was to investigate...

Glutamate modulators as novel interventions for mood disorders.

Revista Brasileira de Psiquiatria September 2005 Sanjay J. Mathew, Kathryn Keegan, Lisa Smith

Recent evidence suggests that critical molecules in neurotrophic signaling cascades are long-term targets for currently available monoaminergic antidepressants. As chronic and severe mood disorders are characterized by impairments in neuronal resilience, pharmacological strategies that subserve a neuroprotective function might alter disorder pathophysiology and modify disease progression....

From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.

Substance Use & Misuse 2005 Jill A. McCaughan, Robert G Carlson, Rüssel S. Falck et al. 43 citations

Although young people attending raves have been most visibly associated with the use of ecstasy and other "club drugs" in the United States, there is reason to believe that they are not a homogenous group in terms of their drug use practices. The purpose of this article is to begin developing a typology of young adult ecstasy users involved in the rave subculture--known as Ravers or Party Kids....

Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism

American Journal of Psychiatry October 1, 2004 Ismene L. Petrakis, Diana Limoncelli, Ralitza Gueorguieva et al. 143 citations

OBJECTIVE: A family history of alcoholism is a risk factor for the development of ethanol dependence. Ethanol is an antagonist of the N-methyl-d-aspartate (NMDA) glutamate receptor, and alterations in NMDA receptor function are thought to be involved in ethanol abuse and dependence. The purpose of this study was to determine in healthy individuals with no ethanol dependence whether response to...

DOI: 10.1176/ajp.161.10.1776 (opens in new tab) Nmda receptor Glutamate receptor Antagonist Vulnerability computing +2

Club drugs: reasons for and consequences of use.

Journal of Psychoactive Drugs September 2004 Kathleen A Parks, Cheryl L Kennedy

This preliminary descriptive study was designed to assess the reasons, primary contexts, and consequences (physical, psychological, lifestyle) of club drug use in a sample of young adults in a mid-size U.S. city. Fifty young adults (18 to 30 years old) reported on their use of club drugs (Ecstasy, GHB, ketamine, Rohypnol, methamphetamine, LSD) in face-to-face interviews that included...